US FDA Presents 3D Printing Scenarios To Spark Discussion, Lead To Future Guidance

The agency recently published a paper to spark discussions in the medtech industry on how to best regulate 3D printing of medical devices at points of care such a clinics and hospitals.

• Source: US Food and Drug Administration

The US Food and Drug Administration wants to hear from the medical device industry on how to regulate 3D-printed manufactured devices at point-of-care (POC) settings. Based on the feedback, it plans to develop a risk-based guidance that is not too burdensome.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Digital Technologies

More from Medtech Insight